🔎 Trials Near Me

Home › Type 2 Diabetes › California › Chula Vista

Type 2 Diabetes clinical trials in Chula Vista, CA

6 studies for Type 2 Diabetes are looking for participants at sites in and around Chula Vista (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

RecruitingHealthy volunteers welcome
  • Cardiovascular Institute of San Diego, Chula Vista
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

RecruitingPhase 2
  • Clinical Trial Site, Chula Vista
Ages 18 to 65 · All sexes · Updated Sep 16, 2026 · NCT07465224

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RecruitingPhase 3
  • AURORA-2 Clinical Site, Chula Vista
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RecruitingPhase 3
  • Velocity Clinical Research Chula Vista, Chula Vista
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144

Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age

Recruiting
  • Scripps Chula Vista Diabetes Center, Chula Vista
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05416060

Latinos Understanding the Need for Adherence in Diabetes Using E-Health

Recruiting
  • South Bay Latino Research Center, Chula Vista
Ages 18 and older · All sexes · Updated Jan 17, 2025 · NCT05570734

About Type 2 Diabetes

Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.

More about Type 2 Diabetes on MedlinePlus

Type 2 Diabetes trials in other cities

Other studies in Chula Vista

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.